Align Technology/$ALGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Align Technology
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Ticker
$ALGN
Sector
Health
Primary listing
Employees
20,945
Headquarters
Website
Align Technology Metrics
BasicAdvanced
$10B
23.44
$5.92
1.61
-
Price and volume
Market cap
$10B
Beta
1.61
52-week high
$256.48
52-week low
$127.70
Average daily volume
1.8M
Financial strength
Current ratio
1.227
Quick ratio
1.011
Long term debt to equity
2.312
Total debt to equity
2.312
Profitability
EBITDA (TTM)
798.038
Gross margin (TTM)
69.94%
Net profit margin (TTM)
11.04%
Operating margin (TTM)
16.24%
Effective tax rate (TTM)
29.49%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
6.50%
Return on equity (TTM)
11.41%
Valuation
Price to earnings (TTM)
23.438
Price to revenue (TTM)
2.584
Price to book
2.57
Price to tangible book (TTM)
3.03
Price to free cash flow (TTM)
16.643
Free cash flow yield (TTM)
6.01%
Free cash flow per share (TTM)
8.338
Growth
Revenue change (TTM)
0.56%
Earnings per share change (TTM)
0.59%
3-year revenue growth (CAGR)
-0.21%
10-year revenue growth (CAGR)
17.42%
3-year earnings per share growth (CAGR)
-8.81%
10-year earnings per share growth (CAGR)
12.77%
What the Analysts think about Align Technology
Analyst ratings (Buy, Hold, Sell) for Align Technology stock.
Align Technology Financial Performance
Revenues and expenses
Align Technology Earnings Performance
Company profitability
Align Technology News
AllArticlesVideos
INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Align Technology, Inc. and Encourages Investors and Potential Witnesses to Contact Law Firm - ALGN
Business Wire·20 hours ago
Buy the Dip? These Earnings Misses Offer Long-Term Upside
MarketBeat·1 day ago
Align Technology Announces $200 Million Open Market Repurchase
Business Wire·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Align Technology stock?
Align Technology (ALGN) has a market cap of $10B as of August 08, 2025.
What is the P/E ratio for Align Technology stock?
The price to earnings (P/E) ratio for Align Technology (ALGN) stock is 23.44 as of August 08, 2025.
Does Align Technology stock pay dividends?
No, Align Technology (ALGN) stock does not pay dividends to its shareholders as of August 08, 2025.
When is the next Align Technology dividend payment date?
Align Technology (ALGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Align Technology?
Align Technology (ALGN) has a beta rating of 1.61. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.